Barclays PLC Heron Therapeutics, Inc. Put Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $876,794 - $1.27 Million	-39,800 Reduced 99.5%	200 $5,000
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $750,000 - $1.02 Million	25,000 Added 166.67%	40,000 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $2.19 Million - $3.48 Million	-82,800 Reduced 84.66%	15,000 $583,000
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $1.8 Million - $2.82 Million	97,800 New	97,800 $2.7 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $182M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.